Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Diagnoses and clinical features associated with high risk for unplanned readmission in vascular surgery. A cohort study.

Yiasemidou M, Mavor AI, Kent PJ.

Ann Med Surg (Lond). 2015 Apr 14;4(2):124-8. doi: 10.1016/j.amsu.2015.04.005. eCollection 2015 Jun.

2.

Resection of recurrent rectal cancer with encasement of external iliac vessels.

Maslekar S, Sagar PM, Mavor AI, Harji D, Bruce C.

Tech Coloproctol. 2013 Feb;17(1):131-2. doi: 10.1007/s10151-011-0787-0. Epub 2011 Nov 18. No abstract available.

PMID:
22095300
3.

Cycling related common femoral artery disease: an unusual case in an otherwise healthy male.

Mughal NA, Rashid ST, Mavor AI.

Ann R Coll Surg Engl. 2011 Oct;93(7):e149-50. doi: 10.1308/147870811X602195.

4.

Short series of emergency stent-graft repair of symptomatic penetrating thoracic aortic ulcers (PTAU).

Girn HR, McPherson S, Nicholson T, Mavor AI, Homer-Vanniasinkam S, Gough MJ.

Vasc Med. 2009 May;14(2):123-8. doi: 10.1177/1358863X08098951.

PMID:
19366818
5.

The clinical significance of below-knee great saphenous vein reflux following endovenous laser ablation of above-knee great saphenous vein.

Theivacumar NS, Darwood RJ, Dellagrammaticas D, Mavor AI, Gough MJ.

Phlebology. 2009 Feb;24(1):17-20. doi: 10.1258/phleb.2008.008004. Erratum in: Phlebology. 2015 Aug;30(7):500. Dellegrammaticas, D [corrected to Dellagrammaticas, D].

PMID:
19155336
6.

Fate of the great saphenous vein following endovenous laser ablation: does re-canalisation mean recurrence?

Theivacumar NS, Dellagrammaticas D, Darwood RJ, Mavor AI, Gough MJ.

Eur J Vasc Endovasc Surg. 2008 Aug;36(2):211-5. doi: 10.1016/j.ejvs.2008.03.014. Epub 2008 May 13.

7.

Endovenous laser ablation: does standard above-knee great saphenous vein ablation provide optimum results in patients with both above- and below-knee reflux? A randomized controlled trial.

Theivacumar NS, Dellagrammaticas D, Mavor AI, Gough MJ.

J Vasc Surg. 2008 Jul;48(1):173-8. doi: 10.1016/j.jvs.2008.01.062. Epub 2008 Apr 28.

8.

Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins.

Darwood RJ, Theivacumar N, Dellagrammaticas D, Mavor AI, Gough MJ.

Br J Surg. 2008 Mar;95(3):294-301. doi: 10.1002/bjs.6101.

PMID:
18278775
9.

Risk factor awareness in patients with peripheral arterial disease.

Coughlin PA, Gulati V, Mavor AI, Gough MJ, Homer-Vanniasinkam S.

J Cardiovasc Surg (Torino). 2007 Dec;48(6):735-40.

PMID:
17947931
10.

Factors influencing the effectiveness of endovenous laser ablation (EVLA) in the treatment of great saphenous vein reflux.

Theivacumar NS, Dellagrammaticas D, Beale RJ, Mavor AI, Gough MJ.

Eur J Vasc Endovasc Surg. 2008 Jan;35(1):119-23. Epub 2007 Nov 1.

11.

Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies.

Girn HR, Ahilathirunayagam S, Mavor AI, Homer-Vanniasinkam S.

Vasc Endovascular Surg. 2007 Aug-Sep;41(4):277-93. Review.

PMID:
17704330
12.

Fate and clinical significance of saphenofemoral junction tributaries following endovenous laser ablation of great saphenous vein.

Theivacumar NS, Dellagrammaticas D, Beale RJ, Mavor AI, Gough MJ.

Br J Surg. 2007 Jun;94(6):722-5.

PMID:
17514655
13.

Endovenous laser ablation (EVLA) of great saphenous vein to abolish "paradoxical reflux" in the Giacomini vein: a short report.

Theivacumar NS, Dellagrammaticas D, Mavor AI, Gough MJ.

Eur J Vasc Endovasc Surg. 2007 Aug;34(2):229-31. Epub 2007 Feb 27.

14.

Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans.

Argimón S, Wishart JA, Leng R, Macaskill S, Mavor A, Alexandris T, Nicholls S, Knight AW, Enjalbert B, Walmsley R, Odds FC, Gow NA, Brown AJ.

Eukaryot Cell. 2007 Apr;6(4):682-92. Epub 2007 Feb 2.

15.

Initial experience in endovenous laser ablation (EVLA) of varicose veins due to small saphenous vein reflux.

Theivacumar NS, Beale RJ, Mavor AI, Gough MJ.

Eur J Vasc Endovasc Surg. 2007 May;33(5):614-8. Epub 2007 Jan 16.

16.

Secondary prevention in patients with peripheral arterial disease: are we letting our patients down?

Vohra RS, Gough MJ, Homer-Vanniasinkam S, Mavor AI, Howell S.

Eur J Vasc Endovasc Surg. 2007 Feb;33(2):190-1. Epub 2006 Dec 11. No abstract available.

17.

The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications.

Fradin C, Mavor AL, Weindl G, Schaller M, Hanke K, Kaufmann SH, Mollenkopf H, Hube B.

Infect Immun. 2007 Mar;75(3):1493-501. Epub 2006 Dec 4.

18.

Arterial consequences of recreational drug use.

Coughlin PA, Mavor AI.

Eur J Vasc Endovasc Surg. 2006 Oct;32(4):389-96. Epub 2006 May 8. Review.

19.

Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes.

Mavor AL, Thewes S, Hube B.

Curr Drug Targets. 2005 Dec;6(8):863-74. Review.

PMID:
16375670
20.

Global role of the protein kinase Gcn2 in the human pathogen Candida albicans.

Tournu H, Tripathi G, Bertram G, Macaskill S, Mavor A, Walker L, Odds FC, Gow NA, Brown AJ.

Eukaryot Cell. 2005 Oct;4(10):1687-96.

21.

Forging a poison prevention and control system: report of an Institute of Medicine committee.

Guyer B, Mavor A; Institute of Medicine Committee on Poison Prevention and Control.

Ambul Pediatr. 2005 Jul-Aug;5(4):197-200.

PMID:
16026183
22.

Minimally invasive treatment for varicose veins: a review of endovenous laser treatment and radiofrequency ablation.

Beale RJ, Mavor AI, Gough MJ.

Int J Low Extrem Wounds. 2004 Dec;3(4):188-97.

PMID:
15866814
23.

Global roles of Ssn6 in Tup1- and Nrg1-dependent gene regulation in the fungal pathogen, Candida albicans.

García-Sánchez S, Mavor AL, Russell CL, Argimon S, Dennison P, Enjalbert B, Brown AJ.

Mol Biol Cell. 2005 Jun;16(6):2913-25. Epub 2005 Apr 6.

24.

CandidaDB: a genome database for Candida albicans pathogenomics.

d'Enfert C, Goyard S, Rodriguez-Arnaveilhe S, Frangeul L, Jones L, Tekaia F, Bader O, Albrecht A, Castillo L, Dominguez A, Ernst JF, Fradin C, Gaillardin C, Garcia-Sanchez S, de Groot P, Hube B, Klis FM, Krishnamurthy S, Kunze D, Lopez MC, Mavor A, Martin N, Moszer I, Onésime D, Perez Martin J, Sentandreu R, Valentin E, Brown AJ.

Nucleic Acids Res. 2005 Jan 1;33(Database issue):D353-7.

25.

Treatment of venous leg ulcers with Dermagraft.

Omar AA, Mavor AI, Jones AM, Homer-Vanniasinkam S.

Eur J Vasc Endovasc Surg. 2004 Jun;27(6):666-72.

26.

Abdominal aortic aneurysm rupture after coronary artery bypass grafting.

Ngaage DL, Sulaiman MS, Mavor A, Kaul P.

Cardiovasc Surg. 2003 Jun;11(3):237-8.

PMID:
12704336
27.

Venous covered stent: successful occlusion of a symptomatic internal iliac arteriovenous fistula.

Cronin P, McPherson SJ, Meaney JF, Mavor A.

Cardiovasc Intervent Radiol. 2002 Jul-Aug;25(4):323-5. Epub 2002 Jun 4.

PMID:
12042989
28.

Evaluation of dermagraft as an alternative to grafting for open fasciotomy wounds.

Omar AA, Mavor AI, Homer-Vanniasinkam S.

J Wound Care. 2002 Mar;11(3):96-7.

PMID:
11933732
29.

Bacterial colonisation of Doppler probes on vascular surgical wards.

Kibria SM, Kerr KG, Dave J, Gough MJ, Homer-Vanniasinkam S, Mavor AI.

Eur J Vasc Endovasc Surg. 2002 Mar;23(3):241-3.

30.

Penetrating atherosclerotic ulcers of the aorta.

Troxler M, Mavor AI, Homer-Vanniasinkam S.

Br J Surg. 2001 Sep;88(9):1169-77. Review.

PMID:
11531862
31.

Differences in the detection of cyclo-oxygenase 1 and 2 proteins in symptomatic and asymptomatic carotid plaques.

Wijeyaratne SM, Abbott CR, Homer-Vanniasinkam S, Mavor AI, Gough MJ.

Br J Surg. 2001 Jul;88(7):951-7.

PMID:
11442526
32.

Arterial thoracic outlet compression syndrome: a differential diagnosis of painful right supraclavicular swelling?

Okereke CD, Mavor A, Naim M.

Hosp Med. 2000 Sep;61(9):672-3. No abstract available.

PMID:
11048615
33.

Regarding "The value of late computed tomographic scanning in identification of vascular abnormalities after abdominal aortic aneurysm repair".

Mushtaq N, Gough MJ, Homer-Vanniasinkam S, Mavor AI.

J Vasc Surg. 1999 Nov;30(5):961-2. No abstract available.

34.

Patient documentation. On the records.

Renvoize E, Grange A, Pinder J, Mavor A, Almarow G, McGowan M.

Health Serv J. 1997 Dec 11;107(5583):30-1.

PMID:
10176080
35.

Does the Warren shunt correct hypersplenism?

Lodge JP, Mavor AI, Giles GR.

HPB Surg. 1990 Mar;2(1):41-7; discussion 48-9.

36.

Clinical evaluation of PBS140 solution for cadaveric renal preservation.

Lam FT, Ubhi CS, Mavor AI, Lodge JP, Giles GR.

Transplantation. 1989 Dec;48(6):1067-8. No abstract available.

PMID:
2595768
37.

Subcutaneous heparin therapy for cyclosporine-immunosuppressed renal allograft recipients.

Ubhi CS, Lam FT, Mavor AI, Giles GR.

Transplantation. 1989 Nov;48(5):886-7. No abstract available.

PMID:
2815265
38.

[Ectopic spleen syndrome].

Lifschitz A, Mavor A, Gindin Y, Barzilai N, Pfefferman R.

Harefuah. 1989 Jun 15;116(12):630-2. Hebrew.

PMID:
2792945
39.

Improved 72-hour renal preservation with phosphate-buffered sucrose.

Lam FT, Mavor AI, Potts DJ, Giles GR.

Transplantation. 1989 May;47(5):767-71.

PMID:
2655211
40.

Distal splenorenal versus lienorenal shunt for acute variceal haemorrhage: is the selective shunt an advance?

Lodge JP, Mavor AI, Giles GR.

J R Coll Surg Edinb. 1989 Apr;34(2):59-62. Review.

PMID:
2657041
41.
42.

Initial clinical experience with degradable starch microspheres.

Mavor AI, Parkin A, Riley A, Smye S, O'Brien T, Robinson PJ, Giles GR.

Nucl Med Commun. 1987 Dec;8(12):1011-8.

PMID:
2835715
43.

Behavioural characteristics of men in the performance of some decision-making task components.

Vaughan WS Jr, Mavor AS.

Ergonomics. 1972 May;15(3):267-77. No abstract available.

PMID:
5052563
44.

Diver performance in controlling a wet submersible during four-hour exposures to cold water.

Vaughan WS Jr, Mavor AS.

Hum Factors. 1972 Apr;14(2):173-80. No abstract available.

PMID:
5022476

Supplemental Content

Support Center